Abstract Psoriasin (S100A7), a member of the S100 gene family, is highly expressed in high-grade comedo ductal carcinoma in situ (DCIS), with a higher risk of local recurrence. Psoriasin is, therefore, a potential biomarker for DCIS with a poor prognosis. High-grade DCIS is characterized by a high proliferation rate and crowded cells, consequently, lose contact with the extracellular matrix. The aim of this study was, therefore, to elucidate the involvement of adhesion signals in the regulation of psoriasin. Protein expression was evaluated by Western blotting, flow cytometry, and immunohistochemistry, and using breast carcinoma SAGE databases available from the CGAP website. Intercellular adhesion molecule 1 (ICAM-1) was down-regulated in MCF10A cells using short hairpin RNA. We found a significant negative correlation between the expression of ICAM-1 and psoriasin, and a positive correlation between psoriasin and MUC1 in normal and DCIS SAGE libraries. In a cluster analysis of 34 adhesion molecules and 20 S100 proteins, we showed that SAGE libraries expressing the S100 proteins-psoriasin, calgranulin-A, and calgranulin-B-clustered together. Interestingly, the expression of all the three proteins correlated strongly to the oncogenic MUC1. We confirmed the negative correlation between ICAM-1 and psoriasin/ MUC1, when normal and breast cancer cells were cultured in suspension and on collagen, respectively. The downregulation of ICAM-1 by short hairpin RNA in MCF10A cells led to the induction of psoriasin, calgranulin-A, calgranulin-B, and MUC1, and we demonstrated that these upregulations were not ROS dependent. By blocking the phospholipase C (PLC)-IP3 pathway in these cells, we showed that the induction of psoriasin diminished. The results suggest that psoriasin is an intracellular calciumdependent target of the PLC pathway. Our findings suggest that the down-regulation of ICAM-1 in mammary epithelial cells may contribute both to the high expression of psoriasin seen in some high-grade DCIS tumors and to the induction of MUC1.
Introduction
Breast cancer is the leading cause of cancer-related deaths in women worldwide [1] . It has become clear that breast cancer is highly heterogeneous at both the clinical and molecular level and that each subtype of breast tumor has its own expression pattern and associated clinical outcome [2] . The specific biological mechanisms that underlie breast cancer initiation and progression remain poorly understood. Improved diagnostic tools have made it possible to detect breast cancer, such as ductal carcinoma in situ (DCIS), in its early stages, but reliable prognostic markers for this heterogeneous group of tumors are still lacking.
The S100 family is a group of calcium-binding proteins that display a change in expression in different carcinomas, including breast cancer. S100 proteins have both intracellular and extracellular functions and have been seen to play a role in various cellular processes including proliferation, differentiation, and cell shape [3] [4] [5] . We and others have identified psoriasin (S100A7) as one of the few proteins that are highly and more frequently expressed in highgrade DCIS than in invasive breast carcinomas. Interestingly, the continuous expression of psoriasin in invasive breast cancer has been associated with a poor clinical outcome [6] [7] [8] [9] . These findings indicate that psoriasin may play a role in breast cancer initiation and progression and could be a potential biomarker for DCIS with a poor prognosis.
We and others have demonstrated that psoriasin expression correlates to increased survival and NFjB signaling in mammary epithelial cells [10, 11] . Psoriasin was found to interact with JUN-activating binding protein1 (Jab1), which is involved in multiple signal transduction pathways, including the regulation of JUN/AP1 transcription factors [12] . We showed that the down-regulation of endogenous psoriasin expression in the MDA-MB-468 cell line by short hairpin RNAs increased invasion in vitro, but inhibited tumor growth in vivo. In accordance with these findings, we demonstrated an up-regulation of matrix metalloproteinase 13 (MMP13) and a down-regulation of vascular endothelial growth factor (VEGF) in cells with reduced psoriasin levels [13] . In addition, psoriasin protein is secreted and can function as a chemotactic factor for CD4
? lymphocytes in the skin and, more recently, it has been implicated in the antibacterial defense mechanism of the skin [14] .
We have previously demonstrated the induction of psoriasin in mammary epithelial cells by growth factor deprivation, prolonged cell confluency [8] , and reactive oxygen species (ROS) [10] . In addition, the most pronounced induction of psoriasin expression was observed by the loss of attachment to the extracellular matrix (suspension culture). All of these conditions may induce the expression of psoriasin in high-grade DCIS in vivo, and thus may play a role in tumorigenesis. The aim of this study was, therefore, to investigate whether loss of cell adhesion signaling may contribute to the high psoriasin expression seen in some high-grade DCIS tumors.
Materials and methods

Cell lines and culture condition
The MDA-MB-468 (human breast cancer) and the MCF10A (immortalized normal breast epithelium) cell lines were obtained from American Type Culture Collection (Manassas, VA, USA) and were cultivated as previously described [15] . For suspension cultures, cells were plated into poly-2-hydroxy-ethylmethacrylate (polyHEMA) (Sigma-Aldrich, Stockholm, Sweden)-coated (10 mg/cm 2 in 95% ethanol) Petri dishes. Effects in confluence were analyzed by maintaining the cells in confluent conditions for 5 days. In order to investigate the relationship between psoriasin and extracellular signaling, cells were plated on collagen-1-treated Petri dishes (Vitrogen; no. FXP-019).
In order to examine the effect of N-acetylcysteine (NAC), cells were incubated with 10 mM of the antioxidant for 1.5 h. In order to investigate the role of phospholipase C (PLC), we tested U73122 (Sigma-Aldrich), a widely employed PLC inhibitor. We also tested 2-APB (Sigma-Aldrich), an IP3-receptor inhibitor. The influence on psoriasin protein expression was investigated for 3-48 h after treatment. The phospholipase C activator, m-3M3FBS (Calbiochem), was incubated for 24 h. H 2 O 2 (SigmaAldrich) was added to a final concentration of 0.4-1.2 mM and incubated for 5 min. After the indicated time, cells were harvested and immediately frozen in liquid nitrogen, or prepared for FACS analysis.
Generation of short hairpin RNA clones
For the generation of stable clones expressing short hairpin RNA (shRNA) for human ICAM-1 (SuperArray, Bioscience Corporation), MCF10A cells were transfected using Lipofectamine ltx with Plus reagent (Invitrogen). Stable clones were selected for 2 weeks in media containing 3 lg/ ml puromycin.
Western blotting
Western blotting was performed as previously described [15] . Western blotting analyses of cell lysate were produced with anti-psoriasin (mouse-Ab) (Imgenex, San Diego, CA, USA) and anti-calgranulin-B (mouse-Ab) (Dianova GmbH, Hamburg, Germany). Moreover, anticalgranulin-A (mouse-Ab), anti-ICAM1 (mouse-Ab), anti-MUC1 (mouse-Ab), and anti-GAPDH (rabbit-Ab) (Santa Cruz Biotechnology, CA, USA) were used. Anti-phosphoPLCc1 (Tyr783) (rabbit-Ab) were purchased from Cell Signaling Technology, USA.
Flow cytometry
Flow cytometry analyses were performed to examine the expression of ICAM-1 and MUC1 on the cell surface. Cells were trypsined and washed with 19 PBS. A total number of 1.5-3 9 10 5 cells were then re-suspended in 19 PBS. Antibodies were added and incubated for 30 min on ice. The antibodies that were used were FITC Mouse anti-human CD227 (MUC1) (BD Bioscience, CA, USA) at a dilution of 1:30 and FITC Mouse anti-CD54 (ICAM-1) (Diaclone, Besancon Cedex, France) at a dilution of 1:50. After another washing, cells were re-suspended in 19 PBS. Flow cytometry was performed using a FACSAria (BD Immunocytometry Systems, Franklin Lakes, NJ).
Tissues
Tissue samples for immunohistochemical study were obtained from the files of the Department of Pathology at Sahlgrenska University Hospital. From a set of cases (n = 11) representing DCIS grades 1, 2, and 3, picked out at random, blocks of paraffin-embedded tissue samples were obtained. The tissue blocks contained tumor tissue and adjacent normal breast tissue. Histologically, the tumors showed some degree of structural heterogeneity. The individual tumors contained a single or several components of papillar, cribriform, solid, and comedotype structures. See online resource 1 for the original data.
Immunohistochemistry
A monoclonal antibody to psoriasin, commercially available from Imgenex (Imgenex, San Diego, CA, USA), a monoclonal anti-MUC1 antibody, and anti-ICAM-1 antibody (Santa Cruz Biotechnology) were used. The psoriasin antibody was used at a dilution of 1:200, the MUC1 antibody at a dilution of 1:500 and ICAM-1 at a dilution of 1:400 (25 min at room temperature). Antigen-antibody complexes were visualized with an ABC detection system using diaminobenzidine (DAB) as the chromogen. The study was performed under conditions approved by the Ethics Committee at the University of Gothenburg. All the slides were evaluated by an experienced breast pathologist (AK).
SAGE genie informatics
SAGE Genie is a Website for the analysis and presentation of SAGE data (http://cgap.nci.nih.gov/SAGE) created by the Cancer Genome Anatomy Project (CGAP) SAGE project. These informatics provide a quantitative view of the transcription levels of selected genes in many different tissues [16] . The tumors used for SAGE analysis were six normal mammary tissues (N1-N6), five high-grade comedo DCIS (D1, D3, D4, D5, and D6), three intermediategrade tumors with no necrosis (D2, D7, and D8), nine invasive tissues, and three metastatic tissues. The SAGE libraries analyzed in this article have been previously reported [17, 18] . Nitro blue tetrazolium (NBT) assay for detection of ROS
The NBT assay was performed as described previously [19] . In brief, NBT (Sigma) was added at a final concentration of 1 mg/ml, and the incubations were carried out at 37°C for 3 h. Intracellular blue formazan particles were dissolved in 960 ll of 2 M KOH (Sigma-Aldrich) and 1120 ll of DMSO, and the OD was then measured as 630 nm using a multi-well plate reader.
Statistical analysis
Correlation analysis was assessed by Spearman's rank correlation test (r). In order to illustrate the relationship between the expressions of two genes, a scatter plot was applied using SPSS 15.0.
Results
Synthetic RGD-containing peptides do not induce psoriasin
Integrin receptors are the main mediators of cell adhesion to the extracellular matrix (ECM). They bind to their ligands by interacting with short amino acid sequences, such as the RGD sequence (Arg-Gly-Asp). This sequence is recognized by many, but not all of the known integrins. This sequence can be blocked by short synthetic peptides containing the RGD sequence. Using this RGD-competitive ligand inhibitor for integrin binding, no induction of psoriasin was observed (data not shown). Integrins recognizing this sequence do not, therefore, appear to influence the regulation of psoriasin expression by ECM contact.
ICAM-1 is negatively correlated to psoriasin expression
We have previously shown that IFN-c down-regulated psoriasin expression induced by suspension culture in normal breast epithelial cells [15] . This finding led to the hypothesis that IFN-c may interfere with the psoriasin- Fig. 1 Hierarchical cluster analysis of adhesion-related molecules and S100 proteins in breast epithelial SAGE libraries. Using SAGE Genie, the quantitative transcription levels of S100 proteins and adhesion molecules were viewed in breast epithelial SAGE libraries.
The expression profiles of normal epithelium and DCIS are compared using cluster analysis. a Dendrogram image demonstrates the degree of relatedness between the tissue samples. Each sample is represented by a single branch at the bottom of the dendrogram. Samples displaying similar patterns of expression are grouped together on closely connected branches of the dendrogram. b Image demonstrates the level of gene expression and is represented by the intensity of green color (low expression), black color (medium expression), and red color (high expression). Each column represents a tissue sample, and each row represents a gene. The three DCIS libraries, D1, D4, and D8, clustered together. These tumors are characterized by the high concomitant expression of psoriasin (S100A7), calgranulin-A (S100A8), calgranulin-B (S100A9), and MUC1
regulating adhesion signaling that is lost in suspension cultures. IFN-c is a multifunctional cytokine that activates the transcription of many genes. Using microarray analysis, de Veer et al. [20] identified [300 interferon-stimulated genes, ISG. Using the ISG database available on their website, 13 adhesion-related molecules stimulated by IFNc were selected (Table 1) . Utilizing the SAGE database available from the CGAP website, the expression level of these IFN-c-stimulated adhesion molecules and psoriasin were analyzed in normal breast tissue and DCIS tumors. In order to find a negative correlation between adhesion molecules and psoriasin, we used one-tailed t-test. Among the 13 candidates studied, ICAM-1 and thrombospondin 1 exhibited significant negative correlations with psoriasin expression in normal and DCIS specimens (Table 1) .
MUC1 is positively correlated to the expression of psoriasin, calgranulin-A, and calgranulin-B In order to further evaluate the role of adhesion molecules potentially involved in the regulation of psoriasin expression, we analyzed 34 adhesion molecules and 20 S100 proteins in normal and DCIS SAGE libraries. A hierarchical cluster algorithm was used to group together samples with similar gene expression characteristics. The three DCIS specimens, D1, D4, and D8, clustered together. These tumors are characterized by the high expression of psoriasin (S100A7), calgranulin-A (S100A8), and calgranulin-B (S100A9) (Fig. 1) . These results were also confirmed by means of k-mean clustering (k = 2). We analyzed the correlation between these three S100 proteins and the expression of the 34 adhesion proteins (Table 2 ). Interestingly, the The median values obtained in control cells were designed as 1, and collagen-cultured cells were normalized to this from the same run. The data are presented as the means and ranges of three independent experiments expression of the tumor-associated MUC1, which is a ligand for intracellular adhesion molecule 1 (ICAM-1), demonstrated a significant positive correlation with the expressions of all three S100 proteins (P \ 0.05).
The expression levels of psoriasin, ICAM-1, thrombospondin 1, and MUC1 are illustrated in Fig. 2 . Specifically, psoriasin, as well as MUC1, were highly up-regulated in DCIS compared with normal breast tissue, while ICAM-1 was down-regulated. Thrombospondin 1 showed low expression levels.
Next, we assessed the relative gene ratios of psoriasin, MUC1 and ICAM-1 in each individual normal and DCIS library. Despite being limited only to a few observations, both psoriasin and MUC1 are positively correlated to each other (Fig. 3a) , and both proteins are negatively correlated to ICAM-1 (Fig. 3b, c) .
ICAM-1 is negatively correlated to psoriasin/MUC1 in suspension culture and when cultured on collagen
We examined the expression of ICAM-1/MUC1/psoriasin in suspension cultures of the immortalized normal epithelial MCF10A. As shown in Fig. 4 , psoriasin and MUC1 are up-regulated when cells are cultured in suspension, whereas ICAM-1 is down-regulated. This finding suggests that the down-regulation of ICAM-1 in suspension culture may contribute to the strong induction of psoriasin and also MUC1.
In order to further investigate the relationship between psoriasin and extracellular signaling, we cultured MDA-MB-468 cells on collagen-treated Petri dishes (Fig. 5) . After three passages, ICAM-1 expression was induced; however, psoriasin and MUC1 expressions were almost abolished. The membrane-bound protein expression was analyzed by FACS analysis. We confirmed that cells cultured on collagen expressed higher levels of ICAM-1, whereas MUC1 expression was down-regulated.
Down-regulation of ICAM-1 expression by shRNA led to the induction of psoriasin, calgranulin-A, calgranulin-B, and MUC1
In order to investigate the direct effect of ICAM-1 gene silencing, we transfected MCF10A cells with shRNA targeting ICAM-1 mRNA. All the three independent transfections generated three stably transfected knockdown clones and a control clone. Figure 6 show that shRNA used against ICAM-1 expression gave rise to induced psoriasin and MUC1 expression. Moreover, the down-regulation of ICAM-1 also led to the over-expression of calgranulin-A and calgranulin-B. Using flow cytometry, we confirmed the significant down-regulation of cell surface ICAM-1 and we also demonstrated a significant up-regulation of cell surface MUC1. In order to confirm that these results were not only restricted to MCF10A cells, HEKn (primary human keratinocyte) transfected with small interfering RNA targeting ICAM-1 mRNA was demonstrated to strongly up-regulate psoriasin (data not shown).
The up-regulation of psoriasin by ICAM-1 shRNA is mediated by the phospholipase C (PLC)-IP3 pathway
The binding of MUC1 to ICAM-1 was found to induce intracellular calcium signaling mediated by the phospholipase C (PLC)-IP3 pathway [21] . In order to evaluate whether the induction of psoriasin is mediated through activation of the PLC pathway, cells were treated with two different inhibitors: the IP3 inhibitor 2-APB and the PLC inhibitor U73122. As shown in Fig. 7a after treatment with 2-APB or U73122. MUC1 was also found to decrease after treatment with these inhibitors (Fig. 8) . Moreover, we also demonstrated that psoriasin was induced by the PLC activator, m-3M3FBS, in MCF10A cells (Fig. 9) . Functionality of the PLC activator, m-3M3FBS, and the inhibitor U73122 was demonstrated by phosphorylation of PLCc1, which confirms an active signaling pathway (Fig. 10) . We have previously demonstrated that psoriasin is induced by ROS and down-regulated by Bcl-2 and other antioxidants like NAC [10] . We, therefore, used NAC in MCF10A ICAM-1-shRNA cells and demonstrated a prominent expression of psoriasin after the treatment (Fig. 11a) . We also applied NBT assay to measure ROS production in MCF10A ICAM-1-shRNA cells with upregulated psoriasin, and compared with control-shRNA cells. We found no difference in intracellular ROS levels (Fig. 11b) . Therefore, ROS cannot explain the upregulation of psoriasin by ICAM-1 downregulation.
We have previously shown that psoriasin is induced by confluent conditions [8] . Moreover, psoriasin is highly expressed in the MDA-MB-468 breast cancer cell line. In order to investigate the involvement of the PLC pathway in the induction of psoriasin in these conditions, we treated confluent MCF10A cells and MDA-MB-468 cells with the IP3-receptor inhibitor 2-APB and the PLC inhibitor U73122. Interestingly, no decrease in psoriasin expression was seen after treatment (Fig. 12) . We used MCF10A cells with a stable retroviral overexpression of psoriasin to detect changes in ICAM-1 and MUC1 expression by flow cytometry (Fig. 13) . A significant yet minor change in ICAM-1 expression was identified. We also investigated the effect of extracellularly administered psoriasin. There was no influence of ICAM-1 or MUC1 expression (data not shown). We, therefore, found no evidence of reciprocal negative regulation between psoriasin and ICAM-1.
Heterogenous expression of psoriasin, ICAM-1, and MUC1 using immunohistochemistry
The expression of psoriasin, ICAM-1, and MUC1 in a set of DCIS cases showed a marked degree of heterogeneity, both between and within samples (see online resource 1). In normal mammary epithelial components, psoriasin was expressed in only one of the cases. In DCIS cells, on the other hand, psoriasin was strongly upregulated but commonly only in a fraction of the cells, often surrounded by cells with no or weak psoriasin expression. However, a few DCIS samples altogether lacked psoriasin expression. MUC1 was weakly to moderately expressed in normal epithelial cells, and strongly in all the DCIS samples except one; this sample was also lacking psoriasin expression. Also, ICAM-1 showed a heterogenous expression, both in normal cells and in the DCIS components. Thus, both normal mammary epithelial cells and DCIS cells showed weak, or even negative to moderate staining. Because of this complex picture, a grading of expression of the different proteins in individual tumors was not found meaningful. Interestingly, in apocrine metaplasia representing differentiated normal epithelial cells, ICAM-1 was downregulated whereas psoriasin was upregulated. Endothelial cells and inflammatory cells stained strongly for ICAM-1 both in the tumor stroma and in the stroma of normal parts of the samples. The staining was strong without the variation in intensity observed in mammary epithelial cells.
Discussion
Adhesion plays a central role in cell survival. Cell-cell interaction and the anchorage of cells to components of the extracellular matrix (ECM) are mediated primarily by integrins and other adhesion molecules [22] . During the initiation of breast cancer, epithelial cells hyper-proliferate leading to changes in adhesion to the basal membrane. In high-grade DCIS, which is an early form of breast cancer, psoriasin is one of the few proteins that is very highly expressed. We have observed that psoriasin is induced in vitro in suspension cultures of normal mammary epithelial cells (MCF10A). IFN-c treatment specifically downregulates psoriasin expression in suspension cultures [15] . Among the adhesion molecules implicated in the cell-cell interactions, CD54 or ICAM-1 has previously been identified to be up-regulated in response to IFN-c at the transcriptional level [22] . ICAM-1 is an important member of the immunoglobulin superfamily (IgSF) of proteins that is essentially involved in the recruitment and trafficking of leukocytes [23] . In contrast to the constitutive expression of ICAM-1 in the endothelium, human epithelial cells normally have a low expression. In the normal and DCIS SAGE libraries, we confirmed a significant negative correlation existing between the expression of psoriasin and ICAM-1 levels. In order to confirm a connection between psoriasin induction and the loss of ICAM-1 expression in normal breast epithelial cells, we demonstrated that ICAM-1 was in fact down-regulated in suspension, making this protein an interesting candidate for further analysis.
We performed a cluster analysis of 34 adhesion molecules and 20 S100 proteins and observed a strong association between the expression of psoriasin, calgranulin-A, and calgranulin-B. Like psoriasin, we have demonstrated that calgranulin-A and calgranulin-B are induced by ROS, confluence, and suspension culture, which supports the assumption that they share common signaling pathways in breast cancer. Their co-expression may suggest that the combined up-regulation of these three proteins reflects a group of breast cancer with a poor prognosis. In line with this, the cluster analysis revealed that all the three proteins correlated strongly to the oncogenic MUC1. MUC1, which is a transmembrane glycoprotein, is an established tumor marker in breast cancer and is implicated in metastatic spread. In addition to psoriasin, calgranulin-A, and calgranulin-B, MUC1 was also induced in suspension cultures of normal breast epithelial cells.
When looking into the relative gene ratios of psoriasin, ICAM-1, and MUC1 in each individual normal and DCIS library in our study, we found a significant negative correlation between ICAM-1 and psoriasin, and a corresponding positive correlation between MUC1 and psoriasin. We confirmed that the negative correlation existed between ICAM-1 and psoriasin/MUC1, when cells were cultured on collagen.
The direct regulatory effect was suggested by the use of shRNA targeting ICAM-1 mRNA in MCF10A cells. The down-regulation of ICAM-1 expression by shRNA thus led to the induction of psoriasin, calgranulin-A, calgranulin-B, and MUC1.
Next, we focused on the mechanism for the up-regulation of psoriasin in the MCF10A cells with reduced expression of ICAM-1. We still detected an expression of psoriasin after treatment with the antioxidant NAC. Moreover, there was no increase in intracellular ROS in cells with reduced expression of ICAM-1. These findings Induction of psoriasin, by ICAM-1 silencing, is not explained by ROS production. a Cells were incubated with 10 mM of the antioxidant NAC for 1.5 h. There was still a prominent expression of psoriasin after the treatments. 60 lg of protein lysate was loaded on the gel. GAPDH assesses equal loading. b We applied NBT assay to measure ROS production in MCF10A ICAM-1-shRNA cells and in MCF10A control-shRNA cells. We found no difference in intracellular ROS levels (P = 0.27, one-tailed t-test). The values are an average of two independent experiments performed in triplicates suggest that signals other than ROS production contribute to the regulation of psoriasin in this context. ICAM-1 is the only known ligand of the MUC1 extracellular domain [24] .
Rahn et al. [21] showed that MUC1 initiates a calciumbased signal mediated by the phospholipase C (PLC)-IP3 pathway, involved in intracellular calcium signaling. Using the inhibitors U73122 and 2-APB for the PLC pathway, the inductions of psoriasin and MUC1 in these cells were reduced. Moreover, the PLC activator, m-3M3FBS, was shown to increase the expression of psoriasin in normal mammary epithelial cells. These findings support the hypothesis that psoriasin is an intracellular calciumdependent target of the PLC pathway. The immunohistochemical analysis from a set of DCIS cases emphasized the high degree of heterogeneity within and between samples. The lack of complete concordance between the results from the analysis of normal and DCIS SAGE libraries compared to the immunohistochemistry may be explained by the fact that SAGE libraries are prepared from fresh tissue and represent mRNA expression, whereas protein expression are assessed in immunohistochemistry. Moreover, the normal mammary epithelial cells within and close to a DCIS lesion may not be regarded as completely normal, since it is known that there is a dramatic change in gene expression in stroma cells surrounding the malignant epithelial cells [25] . MUC1 is implicated in many physiological processes such as adhesion, development, and differentiation. In addition, MUC1 is frequently overexpressed in many cancers including breast cancer with a predominantly cytoplasmic expression [26] . The overexpression of MUC1 is associated with a poorer prognosis and shorter survival in many cancers, including breast cancer. The co-expression of psoriasin and MUC1 may contribute to the poor clinical outcome characteristic for tumors overexpressing psoriasin. Interestingly, both MUC1 and psoriasin correlate with increased survival in response to oxidative stress [10, 27] . Moreover, both proteins have been shown to be regulated by the NFjB pathway [10, 28] . MUC1 affects cancer cell migration by increasing E-cadherin/beta-catenin complex formation [29] , and the down-regulation of psoriasin has also been linked to increased beta-catenin signaling [30] . We now report their co-expression in response to ICAM-1 down-regulation and the positive correlation between their expressions in breast SAGE libraries.
In conclusion, we have presented the data suggesting that the loss of ICAM-1 expression on normal mammary epithelial cells may contribute to the high expression of psoriasin in high-grade DCIS. The upregulation of psoriasin by ICAM1 shRNA was mediated by the phopholipase C (PLC)-IP3 pathway. Furthermore, the downregulation of ICAM-1 led to the induction of calgranulin-A, calgranulin-B, and MUC1.
